Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-02-26

Clinical Trial Update: A Prospective Cohort Study to Improve HCV Care in Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 prospective cohort study to improve hepatitis C care in dialysis patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Hepatitis C | Phase 4 | Status: WITHDRAWN